CONSUMER NEWS    RECALLS    COMPLAINT FORM    SCAM ALERTS  


Complain about a product or service

Small Claims Guide | Class Actions | Lemon Law | FAQ | Resources | Newsletters | Spanish
Automotive    Education    Electronics    Family    Finance    Health    Homeowners    Shopping    Travel   
NEWS   Latest |  Archives |  Auto |  Cells, etc. |  Computers |  Financial |  Health |  Homeowners |  Parents |  Privacy |  Scams |  Seniors |  Travel

Vioxx Study Authors Backtrack On Claim





June 26, 2006

Related Stories

First Vioxx Judgment Overturned On Appeal
Merck Agrees to Pay $58 Million to Settle Vioxx Claims
Researchers Claim Merck Cooked Vioxx Data
Common Pain Relievers May Boost Muscle Mass
More Painkillers Can Cause More Pain
Merck Caves, Agrees To $4.85 Billion Vioxx Settlement
New York Sues Vioxx Maker over Drug’s Risks
Merck Wins Vioxx Case In Illinois
Judge Rules Out Vioxx "Super" Class Action
FDA Critic Blasts Merck's Vioxx Replacement
Merck Loses New Orleans Vioxx Case
Merck Wins Latest Vioxx Suit
Vioxx Study Authors Backtrack On Claim
Older Painkillers May Increase Heart Attack Risk
More about Vioxx
---
Other NSAIDs
Bextra
Celebrex
Dangers of Other Vioxx-Type Drugs
Vioxx Alternatives
Aleve Ingredient Seen as Health Risk

Merck & Co., facing over 1,000 lawsuits because of its now withdrawn painkiller Vioxx, has based much of its defense on research suggesting it takes months of Vioxx use to cause cardiovascular problems. But now the journal that originally advanced that position is backing away.

In a correction on its Web site, the New England Journal of Medicine disavowed the conclusion that it takes 18 months for Vioxx risks to appear. The correction alters the wording of the research paper and the abstract. The research originally appeared in early 2005.

Merck pulled Vioxx, a popular pain reliever widely used by arthritis patients, off the market in September 2004, saying it was "putting patient safety first." However, the Wall Street Journal reported earlier that company officials had fought for years to protect the highly profitable drug and to keep news of the health risks quiet.

Vioxx was a big moneymaker for Merck, generating about $2.5 billion in yearly sales.

So far, Merck has won two Vioxx liability cases and lost two. However, hundreds more are awaiting trial.

The latest trial, in which Merck plaintiffs were awarded a total of $13.5 million, was considered significant because it was the first to involve patients taking the drug for a long period of time.



Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.


Consumer News

July 9 2008

Recent Recalls & Safety Alerts

Print, mail, etc.




FREE CONSUMER NEWSLETTERS

The Daily Consumer
Afternoons M-F

Sign up now!


Consumer News & Alerts
Every Sunday

Sign up now!


Knowledge is free.
Knowledge is power.



Back to the top |

Advertisement


Home | Rogues Gallery | Good Guys | Complaint Form | News | Recalls | Search | Video | FAQ |
Consumer Resources | Small Claims Guide | Lemon Law | Newsletter | Contact Us
Advertise With Us | Testimonials | Newsroom | RSS Feeds | Radio | Job Postings




Terms of Use Your use of this site constitutes acceptance of the Terms of Use

Advertisements on this site are placed and controlled by outside advertising networks. ConsumerAffairs.com does not evaluate or endorse the products and services advertised. See the FAQ for more information.

Company Response Welcome If complaints about your company appear on our site, we welcome your response. Please see the Response Form for more information.

For more information, see the FAQ and privacy policy. The information on this Web site is general in nature and is not intended as a substitute for competent legal advice.  ConsumerAffairs.com Inc. makes no representation as to the accuracy of the information herein provided and assumes no liability for any damages or loss arising from the use thereof. 

Copyright © 2003-2008 ConsumerAffairs.com Inc.  All Rights Reserved.